Publications

  1. Jiang W, Mohamed AS, Kim BYS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 2016 Jul-Aug; 6 (4):241-7 Epub 2015 Nov 10
    View PubMed
  2. Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI, Beadle BM, Frank SJ, Morrison WH, El-Naggar AK, Glisson BS, Sturgis EM, Phan J. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas. Head Neck 2016 Apr; 38 Suppl 1:E1459-66 Epub 2015 Nov 11
    View PubMed
  3. Liu J, Mao K, Jiang S, Jiang W, Chen K, Kim B, Liu Q, Jacobs L. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB. Oncotarget. Nov 2015.
  4. Jiang W, Huang Y, An Y, Kim BYS. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. ACS Nano 2015 Sep 22; 9 (9):8689-96 Epub 2015 July 31
    View PubMed
  5. Jiang W, Huang Y, An Y, Kim BY. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. ACS Nano. 2015 Sep 22; 9(9):8689-96. Epub 2015 Jul 31.
    View PubMed
  6. Jiang W, Gullane P, Gentili F, Kim BYS, DeMonte F. Non-contiguous leptomeningeal metastasis of olfactory neuroblastoma. J Neurooncol.2015;
    View PubMed
  7. Liu J, Jiang W, Mao K, An Y, Su F, Kim BYS, Liu Q, Jacobs LK. Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis. Breast Cancer Res Treat. 2015; 150(2):439-45.
    View PubMed
  8. Kim BY, Jiang W, Beiko J, Prabhu SS, DeMonte F, Gilbert MR, Sawaya R, Aldape KD, Cahill DP, McCutcheon IE. Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing. J Neurooncol. 2014 Jun; 118(2):405-12. Epub 2014 Apr 29.
    View PubMed
  9. Rutka JT, Kim B, Etame A, Diaz RJ. Nanosurgical resection of malignant brain tumors: Beyond the cutting edge. ACS nano. 2014; 8(10):9716-22.
    View PubMed
  10. Kim BY, Jonasch E, McCutcheon IE. Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report. Target Oncol. 2012 Jun; 7(2):145-9. Epub 2012 Feb 29.
    View PubMed
  11. Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010 Dec 16; 363(25):2434-43.
    View PubMed
  12. Kim BY, Jiang W, Oreopoulos J, Yip CM, Rutka JT, Chan WC. Biodegradable quantum dot nanocomposites enable live cell labeling and imaging of cytoplasmic targets. Nano Lett. 2008 Nov; 8(11):3887-92. Epub 2008 Sep 25.
    View PubMed
  13. Jiang W, Singhal A, Kim BYS, Zheng J, Rutka IT, Wang C, Chan WCW. Near-Infrared Emitting Quantum Dots for Deep Tissue, Organ and Animal Imaging Applications. Journal of the Association for Laboratory Automation. 2008; 13(1):6-12.
  14. Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanomaterial-Based Drug Delivery: Progress and Challenges. Expert Opinion in Drug Delivery. 2007; 4:621-3.
  15. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002 May 2; 417(6884):74-8.
    View PubMed
  16. Abounader R, Ranganathan S, Kim BY, Nichols C, Laterra J. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. J Neurochem. 2001 Mar; 76(5):1497-508.
    View PubMed